Regulators examine reports of self-harm, suicidal thoughts among people taking Ozempic, Saxenda
(NEW YORK) -- Regulators in Europe have launched a review after three people in Iceland experienced thoughts of suicide or self-harm after taking popular diabetes and weight loss drugs Ozempic and Saxenda.The review is being led by the European Medicines Agency's Pharmacovigilance Risk Assessment... Read More.